Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of PCV24 in Infants Aged 2-23 Months — Stella

Home/Pneumococcal Infectious Disease/Clinical Trial of PCV24 in Infants Aged 2-23 Months

View on ClinicalTrials.gov

Recruiting

Back to Pneumococcal Infectious Disease trials

Clinical Trial of PCV24 in Infants Aged 2-23 Months

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

China

Shandong Provincial Center for Disease Control and Prevention, Jinan, Shandong

Shanxian Center for Disease Control and Prevention, Shancheng, Shandong

Key details

Phase

Early testing

Sponsor

Sinovac Life Sciences Co., Ltd.

Enrollment target

~180 participants

Started

May 2025

Primary completion

June 2026

Age range

42 Days – 23 Months

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.